David Wilson

David Wilson serves as the Chief Executive Officer of InnovHeart S.r.l. since March 2022, leading advancements in transcatheter mitral valve replacement. Concurrently, David holds the position of President, Global Plasma at Haemonetics, overseeing a $0.5B plasmapheresis and software business addressing the needs of biopharmaceutical companies. Previous roles include Worldwide President at Cordis, where leadership drove significant growth and business turnaround in a $0.9B cardiovascular segment, and Worldwide President at Mentor Worldwide LLC, achieving industry-leading positions in plastic surgery. David has also held various leadership roles at Ethicon and Cordis, focusing on product development and strategic marketing. David's academic credentials include an MBA from Columbia College and advanced degrees in bioengineering and mechanical engineering.